Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNMT1 | P26358 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | WDR5 | P61964 | 1/20 | 0.39 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.37 |
| ▸ | CCR2 | P41597 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.36 |
| ▸ | RORA | P35398 | 1/20 | 0.35 |
| ▸ | RORC | P51449 | 1/20 | 0.35 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.35 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.35 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7636752 | 0.91 | NSD2 (0.43) | MAPTHSP90AA1HSP90AB1ERN1 | |
| SCHEMBL5162395 | 0.85 | MPL (0.39) | MAPTCTRB1HSP90AA1HSP90AB1ERN1 | |
| SCHEMBL9224580 | 0.83 | NPSR1 (0.33) | DNMT1CES1WDR5RORARORC | |
| SCHEMBL3241709 | 0.81 | CA1 (0.57) | CA1CA2CA9ALDH1A1HSD17B10 | |
| SCHEMBL16568785 | 0.81 | ERN1 (0.50) | CA1CA2CA9ALDH1A1HSD17B10 | |
| SCHEMBL29786464 | 0.75 | CA1 (0.64) | DNMT1CES1CA1CA2CA9 | |
| SCHEMBL2785876 | 0.75 | CTRB1 (0.53) | DNMT1CES1CA1CA2CA9 | |
| SCHEMBL29972292 | 0.75 | CTRB1 (0.53) | DNMT1CES1CA1CA2CA9 | |
| Potassium Ion SCHEMBL3628026 | 0.73 | DNMT1 (0.44) | DNMT1CES1CA1CA2CA9 | |
| Ammonia Solution, Strong SCHEMBL3630747 | 0.73 | CTRB1 (0.51) | DNMT1CES1CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-5017491-A | — | — | None | — | — | JP | disclosed |
| EP-1831326-B1 | ELECTROLUMINESCENT POLYMERS AND THEIR USE | MERCK PATENT GMBH (DE) | 2017-03-01 | — | — | EP | disclosed |
| US-20100108989-A1 | ELECTROLUMINESCENT POLYMERS AND USE THEREOF | MERCK PATENT GMBH (DE) | 2010-05-06 | — | — | US | disclosed |
| EP-0503884-B1 | Optically active diphenylphosphino-binaphtyl compounds and catalytic transition metal complexes thereof | TAKASAGO PERFUMERY CO LTD (JP) | 1995-07-26 | — | — | EP | disclosed |
| US-5231202-A | OPTICALLY ACTIVE TERTIARY PHOSPHINE COMPOUND AND TRANSITION METAL COMPLEX USING THE SAME AS LIGAND | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1993-07-27 | — | — | US | disclosed |
| JP-H0517491-A | OPTICALLY ACTIVE TERTIARY PHOSPHINE COMPOUND AND TRANSITION METAL COMPLEX COMPRISING THE SAME COMPOUND AS LIGAND | TAKASAGO INTERNATL CORP | 1993-01-26 | — | — | JP | disclosed |
| EP-0503884-A1 | Optically active diphenylphosphino-binaphtyl compounds and catalytic transition metal complexes thereof | Takasago International Corporation (JP) | 1992-09-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100108989-A1 | ELECTROLUMINESCENT POLYMERS AND USE THEREOF | MAP1LC3C, EPCAM, MAP1LC3A | DNMT1 372/4885CES1 2563/4885CA1 3567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.